Trial
NCT07196124
BCMA/GPRC5D CAR-T Therapy for Multiple Myeloma
Early Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Guangzhou Bio-gene Technology Co., Ltd
Collaborators
—
Condition
Multiple Myeloma Refractory
Intervention
BCMA/GPRC5D CAR-T
Why stopped
Due to corporate strategic adjustment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-28